Katherine Fielding BSc MSc PhD
- Katherine Fielding's Contacts
- Room 108
- Keppel Street
- WC1E 7HT
- T: +44 20 7927 2889
- F: +44 20 7636 8739
Katherine Fielding's Background
I joined the School in 2000 after working as a visiting scientist at the Centers for Disease Control and Prevention, Altanta, US and as a lecturer in medical statistics at the University of Nottingham, UK.
Katherine Fielding's Affiliation
Katherine Fielding's Teaching
I co-organise and teach on the second term module "Statistical Methods in Epidemiology". I also teach in the third term module "Advanced Statistical Methods in Epidemiology" and the distance learning module EP304.
- Randomised controlled trials
Disease and Health Conditions
- Infectious disease
- Sub-Saharan Africa (developing only)
- South Africa
- Analysis Of Longitudinal Data
Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial
Churchyard, G.J.; Fielding, K.; Roux, S.; Corbett, E.L.; Chaisson, R.E.; de Cock, K.M.; Hayes, R.J.; Grant, A.D.
Thorax, 2011; 66(2):134-139
Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis among gold miners in South Africa.
Fielding, K.L.; Grant, A.D.; Hayes, R.J.; Chaisson, R.E.; Corbett, E.L.; Churchyard, G.J.;
Contemp Clin Trials, 2011; 32(3):382-92
Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.
Fielding, K. ; Koba, A. ; Grant, A.D. ; Charalambous, S. ; Day, J. ; Spak, C. ; Wald, A. ; Huang, M.L. ; Corey, L. ; Churchyard, G.J. ;
PLoS One, 2011; 6(10):e25571
Evaluation of the Prognostic Value of IFN-gamma Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal
Lienhardt, C.; Fielding, K.; Hane, A.A.; Niang, A.; Ndao, C.T.; Karam, F.; Fletcher, H.; Mbow, F.; Gomis, J.F.; Diadhiou, R.; Diadhiou, R.; Toupane, M.; Dieye, T.; Mboup, S.;
Plos One, 2010; 5(5):e10508
Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa
Hoffmann, C.J.; Fielding, K.L.; Charalambous, S.; Innes, C.; Chaisson, R.E.; Grant, A.D.; Churchyard, G.J.
AIDS, 2010; 24(11):1709-1716
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening
Churchyard, G.J.; Fielding, K.L.; Lewis, J.J.; Chihota, V.N.; Hanifa, Y.; Grant, A.D.
AIDS, 2010; 24:S19-S27
Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial.
Thiam, S.; LeFevre, A.M.; Hane, F.; Ndiaye, A.; Ba, F.; Fielding, K.L.; Ndir, M.; Lienhardt, C.;
JAMA, 2007; 297(4):380-6
Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
Grant, A.D.; Charalambous, S.; Fielding, K.L.; Day, J.H.; Corbett, E.L.; Chaisson, R.E.; De Cock, K.M.; Hayes, R.J.; Churchyard, G.J.;
JAMA, 2005; 293(22):2719-25
- → View all Katherine Fielding's publications